Jim Simons Ocular Therapeutix, Inc Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 29,700 shares of OCUL stock, worth $194,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,700

Holding current value

$194,832

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.85 - $10.93 $114,345 - $324,621	29,700 New	29,700 $270,000
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $314,963 - $505,547	100,307 Added 402.95%	125,200 $393,000
Q2 2023 Aug 11, 2023	SELL	$4.6 - $7.64 $212,979 - $353,732	-46,300 Reduced 65.03%	24,893 $128,000
Q1 2023 May 12, 2023	SELL	$2.79 - $6.27 $621,612 - $1.4 Million	-222,800 Reduced 75.78%	71,193 $375,000
Q4 2022 Feb 13, 2023	BUY	$2.61 - $4.41 $728,712 - $1.23 Million	279,200 Added 1887.38%	293,993 $826,000

Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $1.5 Million - $2.38 Million	-366,707 Reduced 96.12%	14,793 $61,000
Q2 2022 Aug 12, 2022	SELL	$3.01 - $5.22 $389,208 - $674,972	-129,305 Reduced 25.31%	381,500 $1.53 Million
Q1 2022 May 13, 2022	BUY	$4.83 - $7.35 $2.08 Million - $3.17 Million	430,705 Added 537.71%	510,805 $2.53 Million
Q4 2021 Feb 11, 2022	SELL	$6.16 - $12.07 $1.02 Million - $2 Million	-166,100 Reduced 67.47%	80,100 $558,000
Q3 2021 Nov 12, 2021	SELL	$9.7 - $14.34 $784,943 - $1.16 Million	-80,922 Reduced 24.74%	246,200 $2.46 Million
Q2 2021 Aug 13, 2021	BUY	$13.43 - $19.16 $3.72 Million - $5.31 Million	277,222 Added 555.56%	327,122 $4.64 Million
Q1 2021 May 13, 2021	SELL	$15.82 - $22.11 $4.5 Million - $6.28 Million	-284,166 Reduced 85.06%	49,900 $819,000
Q4 2020 Feb 10, 2021	BUY	$7.91 - $22.95 $2.64 Million - $7.67 Million	334,066 New	334,066 $6.92 Million

Others Institutions Holding OCUL

# of Institutions

149

Shares Held

123M

Call Options Held

185K

Put Options Held

507K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $505M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account